The global craniomaxillofacial (CMF) devices/systems market size was valued at USD 1.28 billion in 2016 and is expected to grow at a CAGR of 8.6% over the forecast period. Increasing demand for minimally invasive surgeries is expected to drive the CMF devices market during the forecast period.
Rising incidences of road accidents due to urbanization & industrialization and rising demand for effective reconstructive surgeries are expected to enable positive CMF device industry growth. Increasing prevalence of facial fractures is expected to result mainly from combat sports (approximately 80%). Nose and teeth accounted for the most injured areas and therefore requires more attention pertaining to prevention measures.
U.S. craniomaxillofacial devices market by product, 2014 - 2025 (USD million)
Out of all the combat sports, kickboxing accounted for the most injurious sport as it resulted in the highest number of maxillofacial trauma. There exists significant demand for more craniomaxillofacial implants owing to increasing prevalence of facial fractures
In addition, increasing awareness levels amongst consumers are one of the key contributing factors for the market growth. For instance, organizations such as American Society of Craniofacial Surgery (ASCFS) and International Society of Craniofacial Surgery (ISCFS) are conducting the research program in a probe to increase awareness pertaining to CMF surgeries.
Moreover, growing geriatric population base and rising healthcare expenditures are some other factors presumed to drive the demand for CMF surgeries over the forecast period. Incorporation of technologically advanced 3D printed implants used in cranial reconstructive surgery aimed at increasing adoption is further anticipated to provide this market with lucrative growth opportunities.
Craniomaxillofacial devices product segment encompasses temporomandibular joint (TMJ) replacement, CMF distraction, cranial flap fixation, CMF plate and screw fixation, bone graft substitutes, and thoracic fixation. CMF plate and screw fixation dominated the product segment in 2016.
This dominance is attributed to its wide usage in various surgical procedures such as deformity correction, orthognathic surgery, tumor removal, and pediatric surgeries. Technological advancement such as introduction of titanium cranial fixation system and increasing efficacy of the devices are the factors contributing towards the growth of cranial flap fixation segment over the forecast period. Moreover, bioabsorbable polymers based implants are likely to gain popularity in near future, contributing toward the segment growth.
TMJ replacement devices are expected to witness fastest growth rate over the forecast period due to increasing incidences of road accidents and sports injuries leading to cranial and facial fractures. TMJ devices are used in prosthetic jaw replacement surgery. It has various applications including fused joints, fractures, degenerated joints, abnormalities, and arthritic conditions. These devices help in reducing jaw pain, interference with eating and increases mouth opening capacity.
TMJ replacement implants have two basic types such as partial and total. Partial TMJ implant is used to resurface the fossa and provides the surface for natural mandibular condyle. Total TMJ implant includes upper and lower component to replace the condyle. It is the fastest growing segment, due to increasing number of cosmetic surgery such as chin augmentation and jaw replacement for improving the appearance of the face.
Metallic implants dominated the overall material market owing to the associated advantages of being less corrosive in nature, providing rigid support to the fractures, comparatively cheaper than bioabsorbable counterparts and higher market penetration than other materials. Metals are used in the CMF surgery because they are less corrosive in nature and physiologically support the fractures.
Titanium and its alloy are most commonly used metals for CMF surgery due to advantage associated with it such as light weight, inert metallic property, strength provided to implants, high tissue acceptance, and corrosion resistance. It is used in the mandibular reconstruction.
Bioabsorbable materials are expected to register lucrative growth over the forecast period, as usage of these implants nullifies the chances of a second surgery, required in case of metallic implants and easy assimilation in the body system. Technological advancement in the CMF surgery, for example, self-inforced technology and advantages associated with it such as biocompatible, easily handled, degradable property and reliability are the factors expected to propel the market growth.
Furthermore, increasing government initiatives aimed at creating awareness pertaining to the use of CMF surgeries in the correction of deformities is also expected to widen the consumer base for the segment growth in coming years.
Neurosurgery and ENT held the largest revenue share as of 2016, owing to increasing incidence rate of trauma and spinal disorders requiring cerebrospinal fluid (CSF) management during surgery. Moreover, adoption of deep brain stimulation procedures is one of the key contributing factors for this segment growth. In deep brain stimulation, the implants are used to cover the skull after inserting the electrode.
Neurosurgical application of cranial implants consists of skull surgery and otolaryngology procedures. These devices assist in treating neuro-oncology, neurovascular diseases, spinal disorders, dura mater repair, transnasal skull based surgery, deep brain stimulation, pelvic or cranial trauma, and CSF management. Medpor bioabsorbable implants are most commonly used for neurosurgery.
In addition introduction of surgical navigation technology for ENT procedures is expected to fuel the market growth over the forecast period. Advantages associated with this technology such as ease of use, 3D display, and real time virtual anatomy updates are anticipated to boost the adoption rates in near future.
Plastic surgery is expected to grow at the fastest CAGR owing to growing awareness and demand for aesthetic procedures and increasing expenditure on cosmetic surgeries especially in developed economies such as the U.S. Additionally, craniomaxillofacial devices are used in maxillofacial oncologic and reconstructive surgery collectively referred as MORS are expected to gain popularity in coming years which thereby contributing towards the segment growth.
North American countries dominated the overall market in terms of revenue share in 2016 owing to increasing incidence of facial deformities and facial fractures. Furthermore, the introduction of technologically advanced cranial implants, rising demand for minimally invasive surgeries, the presence of sophisticated healthcare infrastructure and high patient awareness levels are the factors attributing to the impressive growth of craniomaxillofacial devices in this region.
U.S. accounted for the largest revenue share in 2016. Increasing demand for outpatient activities and rising prevalence of healthcare associated infections are the key contributing factors towards the largest revenue share of this market. In addition, rising burden from government authorities to implement safety guidelines is expected to propel the growth over the forecast period
The presence of untapped opportunities, constantly improving healthcare infrastructure, economic development, and rising patient awareness levels are key impact rendering drivers, accounting for the lucrative growth of craniomaxillofacial industry in Asia Pacific region.
The craniomaxillofacial system market is highly competitive in nature and dominated by a limited number of players. The most notable participants are DePuy Synthes (J&J), Stryker, Medtronic and Zimmer-Biomet account for a significant revenue share of the craniomaxillofacial devices industry in the U.S. due to their extensive product offerings.DePuy Synthes continued introducing innovative new products that carry a smaller profile and provide good outcomes for patients resulting in capturing more revenue share.
Manufacturers are involved in the establishment of extensive distribution systems to increase geographical reach, collaborative strategies, and expansion of product portfolio. For instance, In March 2015, Stryker launched the next generation viable bone matrix at the American academy of Orthopedic Surgeons, which is used for the bone regeneration procedures. This new product launch is implemented to capture the new market for the craniomaxillofacial division.
In addition, the demand for low cost & effective products is increasing from consumer end which in turn is expected to keep the competition at a high level. Many small medical device manufacturers are involved in the development of technologically advanced products with greater efficiency.
For instance, in January 2017, OSSDSIGN received the FDA approval for its OSSDSIGN Cranial implants. This implant helps in preventing infection and it can be fully customized to patient’s fit. These aforementioned benefits with its usage are expected to widen its usage rates over the forecast period.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2017 - 2025
Revenue in USD Million and CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, UK, Germany, Japan, China, India, Brazil, Mexico, South Africa
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global craniomaxillofacial devices/systems market on the basis of product, material, application, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Cranial Flap Fixation
Temporomandibular Joint Replacement
Bone Graft Substitute
MF Plate and Screw Fixation
Material Outlook (Revenue, USD Million, 2014 - 2025)
Application Outlook (Revenue, USD Million, 2014 - 2025)
Neurosurgery & ENT
Orthognathic and Dental Surgery
Regional Outlook (Revenue, USD Million, 2014 - 2025)
The Middle East and Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."